Dr Kaufman presents results at AACR 2017 of a trial administering avelumab to patients with advanced Merkel cell carcinoma who had not responded to chemotherapy. Slides from this presentation are available here, and you can read more about the results...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2osTpBu
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1tk1BEi via IFTTT
-
The National Booster Club Training Council, Providing Guidance, Education, Training and Support from #AlexandrosSfakianakis via Alexandros...
-
PSA! Has a TON of Scholarship Opportunities Right Now. SPOILER: college is crazy-expensive. Sorry. Did we spoil it? There are... from #Ale...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2p6KhjG via IFTTT
-
Fun math practice! Improve your skills with free problems in 'Solve two-step equations' and thousands of other practice lessons. f...
-
Purpose. To assess the long-term clinical outcomes of conventional laser in situ keratomileusis (LASIK) for moderate to high myopia. Methods...
-
How to Write a Master's Thesis. Students learning how to write a Master's Thesis will first learn that a central thesis question mus...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nA3sSF via IFTTT
-
An in-depth look at what makes Rolex the industry leader and icon that they are, as we bring you inside the Rolex manufacturing facilities. ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου